Sai Parenterals Limited (SAIPARENT) — Announcement(2 announcements)
Sai Parenterals announced its subsidiary Noumed Pharmaceuticals secured an exclusive OTC medicine supply agreement with Australia's leading pharmacy network valued at AUD 202 million (INR 1300 crores), effective 1 July 2026 for 7.5 years with a possible 3-year extension.
Sai Parenterals announced that its Australian subsidiary Noumed Pharmaceuticals renewed an exclusive OTC supply agreement with major Australian pharmacy chains for 7.5 years, valued at AUD 202 million (INR 1300 crores), expanding recurring revenue and international footprint. The deal locks in predictable income, adds 12 new products annually, and strengthens regulatory and manufacturing capabilities in a key regulated market, enhancing long-term growth potential for the parent company.
About Sai Parenterals Limited (SAIPARENT)
Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE
📡 Get AI alerts when SAIPARENT files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track SAIPARENT — Free💡 Ask AI about this filing
📊 More SAIPARENT filings
- Announcement — 18 July 2026 Sai Parenterals Limited announced compliance with SEBI Depositories and Participants Regulations 201...
- 🟡 Board Meeting — 6 July 2026 Sai Parenterals Limited announced the outcomes of its board meeting held on July 6, 2026, appointing...
- Financial Results — 29 June 2026 Sai Parenterals Limited announced that its trading window will close on 01.07.2026 for all designate...
- Announcement — 28 May 2026 Sai Parenterals Limited announced it received a USD 11 million purchase order at Rs.95 per share (Rs...
- Announcement — 27 May 2026 Sai Parenterals Limited announced that the audio recording of its Q4 and FY2026 earnings call held o...
🔥 Also filed on 1 July 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
📡 Get AI alerts when SAIPARENT files new disclosures
Track SAIPARENT filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track SAIPARENT — FreeFree account · 2 AI queries/day
© 2026 StockFin.ai — AI-powered Indian stock research